UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Systolic Blood Pressure Lowering on the Risk of Stroke

Hypertension (Dallas, Tex. 1979), 2022-04, Vol.79 (4), p.785-793

2022

Volltextzugriff (PDF)

Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes

BMC nephrology, 2021-02, Vol.22 (1), p.69-69, Article 69

2021

Volltextzugriff (PDF)

Increasing Mortality in Adults With Diabetes and Low Estimated Glomerular Filtration Rate in the Absence of Albuminuria

Diabetes care, 2018-04, Vol.41 (4), p.775-781

2018

Volltextzugriff (PDF)

The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes

Diabetes care, 2020-08, Vol.43 (8), p.1878-1884

2020

Volltextzugriff (PDF)

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT

Journal of the American Society of Nephrology, 2019-08, Vol.30 (8), p.1523-1533

2019

Volltextzugriff (PDF)

Self-reported Intentional Weight Loss and Risk of Death in Moderate Chronic Kidney Disease in the United States

Journal of renal nutrition, 2018-11, Vol.28 (6), p.422-427

2018

Volltextzugriff (PDF)

Associations of Hyponatremia with Cognition Function and All-Cause Mortality: Post Hoc Analysis of the Systolic BP Intervention Trial

Kidney360, 2023-10, Vol.4 (10), p.1362-1370

2023

Volltextzugriff (PDF)

Therapeutic Plasma Exchange-Related Hypotension: A Comparison of Replacement Fluids: SA-PO711

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.926-926

2023

Volltextzugriff (PDF)

The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Incident Strokes in the SPS3 Trial: PO2092

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.642-642

2020

Volltextzugriff (PDF)

The Influence of Baseline Diastolic Blood Pressure on the Effects of Blood Pressure Lowering on Death and ESKD Outcome: PO2093

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.642-643

2020

Volltextzugriff (PDF)

A Pilot and Feasibility Randomized Clinical Trial Targeting Sedentary Behavior in CKD: Sit Less, Interact and Move More (SLIMM) Study: PO0586

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.228-228

2020

Volltextzugriff (PDF)

Advanced CKD Augments the Risk of Hypoglycemia with Insulin Use: PO0971

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.333-333

2020

Volltextzugriff (PDF)

Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure with Reduced Ejection Fraction (HFrEF), and the Risk of ESKD in Type 2 Diabetes (T2D): FR-PO357

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

Incidence of Heart Failure in CKD Patients Is Not Affected by Rurality: TH-PO710

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.249-250

2022

Volltextzugriff (PDF)

Race and the Risk of Heart Failure in CKD: TH-PO709

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.249-249

2022

Volltextzugriff (PDF)

Heart Failure: A Risk Factor for Progression to ESKD: TH-PO634

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.227-227

2022

Volltextzugriff (PDF)

Influence of Baseline Depressive Symptoms on the Effect of Blood Pressure (BP) Intervention on Cognitive Outcomes in the SPRINT Trial: TH-PO233

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.155-155

2023

Volltextzugriff (PDF)

Depressive Symptoms and Achieving Blood Pressure (BP) Goals in the Systolic Blood Pressure Intervention Trial (SPRINT): TH-PO234

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.155-155

2023

Volltextzugriff (PDF)

Trends of Blood Pressure Control in CKD Among US Adults: Findings from the National Health and Nutrition Examination Survey 2011-2020: TH-PO236

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.156-156

2023

Volltextzugriff (PDF)

Insulin Use and CKD Are Risk Factors for Mild Cognitive Impairment (MCI) or Dementia in Persons with Type 2 Diabetes: PO2283

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.698-698

2021

Volltextzugriff (PDF)

Longitudinal Changes in FGF-23 and High-Sensitivity C-Reactive Protein with Incident CKD in the Accord-BP Trial: PO1794

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.554-555

2021

Volltextzugriff (PDF)

Depression and CKD as Risk Factors of Heart Failure: Post Hoc Analysis of SPRINT: FR-PO748

Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.526-527

2022

Volltextzugriff (PDF)

SGLT2 Inhibitors, Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists, and the Risk of Hypokalemia and Hyperkalemia in a National Cohort of Veterans with Type 2 Diabetes: TH-PO1058

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

Risk of Gastroparesis Is Higher with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) but Risk of Death Is Higher with Insulin Glargine in Veterans with Type 2 Diabetes and CKD: TH-PO1057

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

SGLT2 Inhibitors Are Associated with Lower Risk of CKD Progression in Type 2 Diabetes (T2D) than Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs): An Emulated Clinical Trial: FR-PO319

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

1 – 25 von 322

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(300)
Mit Volltextzugriff
(276)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(165)
Humans
(123)
Male
(83)
Female
(77)
Middle Aged
(60)
Adult
(47)
Aged
(45)
Biological And Medical Sciences
(32)
Respiratory System
(29)
Animals
(27)
General & Internal Medicine
(27)
Medical Sciences
(26)
Microbiology
(23)
Chronic Obstructive Pulmonary Disease
(20)
Infectious Diseases
(20)
Aged, 80 And Over
(17)
Adolescent
(16)
Physical Sciences
(16)
Risk Factors
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Systolic Blood Pressure Lowering on the Risk of Stroke

Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes

Increasing Mortality in Adults With Diabetes and Low Estimated Glomerular Filtration Rate in the Absence of Albuminuria

The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT

Self-reported Intentional Weight Loss and Risk of Death in Moderate Chronic Kidney Disease in the United States

Associations of Hyponatremia with Cognition Function and All-Cause Mortality: Post Hoc Analysis of the Systolic BP Intervention Trial

Therapeutic Plasma Exchange-Related Hypotension: A Comparison of Replacement Fluids: SA-PO711

The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Incident Strokes in the SPS3 Trial: PO2092

The Influence of Baseline Diastolic Blood Pressure on the Effects of Blood Pressure Lowering on Death and ESKD Outcome: PO2093

A Pilot and Feasibility Randomized Clinical Trial Targeting Sedentary Behavior in CKD: Sit Less, Interact and Move More (SLIMM) Study: PO0586

Advanced CKD Augments the Risk of Hypoglycemia with Insulin Use: PO0971

Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure with Reduced Ejection Fraction (HFrEF), and the Risk of ESKD in Type 2 Diabetes (T2D): FR-PO357

Incidence of Heart Failure in CKD Patients Is Not Affected by Rurality: TH-PO710

Race and the Risk of Heart Failure in CKD: TH-PO709

Heart Failure: A Risk Factor for Progression to ESKD: TH-PO634

Influence of Baseline Depressive Symptoms on the Effect of Blood Pressure (BP) Intervention on Cognitive Outcomes in the SPRINT Trial: TH-PO233

Depressive Symptoms and Achieving Blood Pressure (BP) Goals in the Systolic Blood Pressure Intervention Trial (SPRINT): TH-PO234

Trends of Blood Pressure Control in CKD Among US Adults: Findings from the National Health and Nutrition Examination Survey 2011-2020: TH-PO236

Insulin Use and CKD Are Risk Factors for Mild Cognitive Impairment (MCI) or Dementia in Persons with Type 2 Diabetes: PO2283

Longitudinal Changes in FGF-23 and High-Sensitivity C-Reactive Protein with Incident CKD in the Accord-BP Trial: PO1794

Depression and CKD as Risk Factors of Heart Failure: Post Hoc Analysis of SPRINT: FR-PO748

SGLT2 Inhibitors, Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists, and the Risk of Hypokalemia and Hyperkalemia in a National Cohort of Veterans with Type 2 Diabetes: TH-PO1058

Risk of Gastroparesis Is Higher with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) but Risk of Death Is Higher with Insulin Glargine in Veterans with Type 2 Diabetes and CKD: TH-PO1057

SGLT2 Inhibitors Are Associated with Lower Risk of CKD Progression in Type 2 Diabetes (T2D) than Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs): An Emulated Clinical Trial: FR-PO319

Suchergebnisse filtern